Stebėti
Radoslaw Zagozdzon
Radoslaw Zagozdzon
Nežinomas ryšys
Patvirtintas el. paštas wum.edu.pl
Pavadinimas
Cituota
Cituota
Metai
Interleukin 12: still a promising candidate for tumor immunotherapy?
W Lasek, R Zagożdżon, M Jakobisiak
Cancer Immunology, Immunotherapy 63, 419-435, 2014
5322014
Oxidative stress in kidney diseases: the cause or the consequence?
N Krata, R Zagożdżon, B Foroncewicz, K Mucha
Archivum immunologiae et therapiae experimentalis 66, 211-220, 2018
1162018
Targeting negative and positive immune checkpoints with monoclonal antibodies in therapy of cancer
K Marhelava, Z Pilch, M Bajor, A Graczyk-Jarzynka, R Zagozdzon
Cancers 11 (11), 1756, 2019
1142019
Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice
W Feleszko, R Zagożdżon, J Gołąb, M Jakobisiak
European Journal of Cancer 34 (3), 406-411, 1998
1091998
Antitumor effects of interleukin-12 in pre-clinical and early clinical studies
J Golab, R Zagozdzon
International journal of molecular medicine 3 (5), 537-581, 1999
971999
Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF
J Goląb, G Wilczyński, R Zagożdżon, T Stoklosa, A Dąbrowska, ...
British journal of cancer 82 (8), 1485-1491, 2000
882000
Intrinsic functional potential of NK-cell subsets constrains retargeting driven by chimeric antigen receptors
VYS Oei, M Siernicka, A Graczyk-Jarzynka, HJ Hoel, W Yang, D Palacios, ...
Cancer immunology research 6 (4), 467-480, 2018
832018
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer
PC O’Leary, M Terrile, M Bajor, P Gaj, BT Hennessy, GB Mills, ...
Breast Cancer Research 16, 1-15, 2014
632014
Immunomodulation by anticancer chemotherapy: more is not always better
R Zagozdzon, J Golab
International journal of oncology 18 (2), 417-424, 2001
602001
Direct stimulation of macrophages by IL-12 and IL-18—a bridge too far?
J Gołąb, R Zagożdżon, T Stokłosal, R Kamiński, K Kozar, M Jakóbisiak
Immunology letters 72 (3), 153-157, 2000
602000
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
PC O“ Leary, SA Penny, RT Dolan, CM Kelly, SF Madden, E Rexhepaj, ...
BMC cancer 13, 1-13, 2013
582013
Effective chemo‐immunotherapy of L1210 leukemia in vivo using interleukin‐12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin
R Zagozdzon, J Gołab, T Stokłosa, A Giermasz, D Nowicka, W Feleszko, ...
International journal of cancer 77 (5), 720-727, 1998
571998
Potentiation of the anti‐tumor effect of actinomycin D by tumor necrosis factor α in mice: Correlation between in vitro and in vivo results
W Lasek, A Giermasz, K Kuc, A Wańkowicz, W Feleszko, J Golab, ...
International journal of cancer 66 (3), 374-379, 1996
561996
Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma
A Trzeciecka, S Klossowski, M Bajor, R Zagozdzon, P Gaj, A Muchowicz, ...
Oncotarget 7 (2), 1717, 2016
552016
Statins impair glucose uptake in human cells
D Nowis, A Malenda, K Furs, B Oleszczak, R Sadowski, J Chlebowska, ...
BMJ Open Diabetes Research and Care 2 (1), e000017, 2014
542014
Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents
M Bajor, AO Zych, A Graczyk-Jarzynka, A Muchowicz, M Firczuk, ...
British Journal of Cancer 119 (7), 873-884, 2018
532018
Carboxyl-Terminal Src Kinase Homologous Kinase Negatively Regulates the Chemokine Receptor CXCR4 through YY1 and Impairs CXCR4/CXCL12 (SDF-1α)–Mediated Breast Cancer Cell Migration
BC Lee, TH Lee, R Zagozdzon, S Avraham, A Usheva, HK Avraham
Cancer research 65 (7), 2840-2845, 2005
522005
Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice.
J Golab, T Stoklosa, A Czajka, A Dabrowska, M Jakobisiak, R Zagozdzon, ...
Anticancer research 20 (3A), 1717-1721, 2000
512000
Truncated HER2: implications for HER2-targeted therapeutics
R Zagozdzon, WM Gallagher, J Crown
Drug discovery today 16 (17-18), 810-816, 2011
442011
Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy
A Domagala, J Stachura, M Gabrysiak, A Muchowicz, R Zagozdzon, ...
BMC cancer 18, 1-10, 2018
432018
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20